Tsuchiya, Tomoshi <br/><br/>
A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.  [electronic resource] 

 -  Clinical lung cancer  Nov 2012 
 - 464-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1938-0690 
<br/><br/><label>Standard No.: </label>10.1016/j.cllc.2012.01.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Ambulatory Care--methods<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Drug Combinations<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Incidence<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Oxonic Acid--administration & dosage<br/>Tegafur--administration & dosage<br/>Treatment Outcome